Back to Results
First PageMeta Content
Pharmacology / Pharmaceutical sciences / Clinical research / Pharmaceutical industry / Drug safety / Center for Biologics Evaluation and Research / FDA Fast Track Development Program / Biologic / Center for Drug Evaluation and Research / Food and Drug Administration / Health / Medicine


Guidance for Industry Available Therapy U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
Add to Reading List

Open Document

File Size: 175,57 KB

Share Result on Facebook

City

Rockville / /

Event

Product Issues / /

Facility

Rockville Pike / /

IndustryTerm

biological products / biologics license applications / prevention of a serious or life-threatening disease / drug product / improvement compared to marketed products / biological product / therapy for a disease / particular product / treatment protocol / drug products / treatment of a serious disease / /

MedicalCondition

disease / serious disease / immediately life-threatening disease / /

MedicalTreatment

treatment protocol / alternate therapies / alternative therapy / investigational therapies / surgery / /

Organization

U.S. Department of Health and Human Services / Food and Drug Administration Center for Drug Evaluation and Research / Training and Communications Division of Drug Information / Food and Drug Administration / Center for Biologics Evaluation / office of Training / HFD-240 Center for Drug Evaluation / U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research / Center for Biologics Evaluation and Research / Center for Biologics Evaluation and Research Food and Drug Administration / office of Communication / Training and Manufacturers Assistance / /

/

Product

postmarketing restrictions / /

ProvinceOrState

Maryland / Indiana / /

Technology

treatment protocol / Drug Development / /

URL

http /

SocialTag